Related references
Note: Only part of the references are listed.Correlation of GPNMB expression with outcome in breast cancer (BC) patients treated with the antibody–drug conjugate (ADC), CDX-011 (CR011-vcMMAE).
M. N. Saleh et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer
April A. N. Rose et al.
CLINICAL CANCER RESEARCH (2010)
Antibody-drug conjugates: targeted drug delivery for cancer
Stephen C. Alley et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
New Antibody Conjugates in Cancer Therapy
Serengulam V. Govindan et al.
THESCIENTIFICWORLDJOURNAL (2010)
Immunological Approaches in the Treatment of Metastasized Breast Cancer
Volkmar Mueller et al.
BREAST CARE (2009)
Osteoactivin promotes breast cancer metastasis to bone
April A. N. Rose et al.
MOLECULAR CANCER RESEARCH (2007)
Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB
Vincent A. Pollack et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Antibody-drug conjugates designed to eradicate tumors with homogeneous and heterogeneous expression of the target antigen
YV Kovtun et al.
CANCER RESEARCH (2006)
CR011, a fully human monoclonal anti body-auristatin E conjugate, for the treatment of melanoma
KF Tse et al.
CLINICAL CANCER RESEARCH (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effect of screening and adjuvant therapy on mortality from breast cancer
DA Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model
JN Rich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells
M Onaga et al.
JOURNAL OF HEPATOLOGY (2003)
Share Paper
